Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients

NCT07412548 | Not Yet Recruiting

• 1 other identifier: UMS-HD-ARMR-2026-01
• Study Type: interventional
• Target: 76
• Locations: 1 country
• Sites: 1

Brief Summary

This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.

Conditions

Chronic Kidney Disease Stage V; End-Stage Renal Disease; Hemodialysis

Keywords

Autogenic Relaxation; Murottal Therapy; Anxiety; Sleep Quality; Hemodynamics

Outcome Measures

Primary Outcomes (4)

• Anxiety

  Change in anxiety level measured using the Zung Self-Rating Anxiety Scale (ZSAS; range 20-80), where higher scores indicate greater anxiety, from baseline to after completion of the 6-week intervention.

  Baseline and after completion of the 6-week intervention

• Sleep Quality

  Change in sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI; range 0-21), where higher scores indicate poorer sleep quality, from baseline to after completion of the 6-week intervention.

  Baseline and after completion of the 6-week intervention.

• Blood Presure

  Change in systolic blood pressure (mmHg), measured using a calibrated digital sphygmomanometer, from baseline to after completion of the 6-week intervention.

  Baseline and after completion of the 6-week intervention

• Heart Rate

  Change in heart rate (beats per minute, bpm), measured using a digital bedside patient monitor, from baseline to after completion of the 6-week intervention.

  Baseline and after completion of the 6-week intervention

Study Arms (2)

Autogenic Relaxation and Murottal Therapy Surah Ar-Rahman

EXPERIMENTAL

Participants in this group receive structured autogenic relaxation followed by Surah Ar-Rahman murottal therapy during hemodialysis sessions. The intervention is administered twice weekly for six weeks, with each session lasting 10-15 minutes. The procedure is conducted by trained nurses under researcher supervision in a quiet and comfortable environment.

Behavioral: Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy

Standard Care

ACTIVE COMPARATOR

listening to dangdut music for 10 to 15 minutes within 6 weeks

Other: listening to dangdut music

Interventions

Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy BEHAVIORAL

A structured non-pharmacological intervention consisting of autogenic relaxation techniques including breathing regulation, muscle relaxation, and self-suggestion, followed by listening to Surah Ar-Rahman murottal recitation using earphones. Each session lasts 10-15 minutes and is conducted twice weekly for six weeks during routine hemodialysis.

Autogenic Relaxation and Murottal Therapy Surah Ar-Rahman

listening to dangdut music OTHER

listening to dangdut music for 10 to 15 minutes within 6 weeks

Standard Care

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients diagnosed with stage V chronic kidney disease.
• Undergoing scheduled hemodialysis at least twice a week for 6 weeks.
• Outpatients and aged 18-65 years.
• Muslim.
• Cooperative and able to communicate verbally.
• Willing to be a respondent by signing an informed consent form.

You may not qualify if:

• Having a severe heart condition or an unstable critical condition.
• Having a severe psychiatric disorder (schizophrenia, major depression).
• Having a cognitive, hearing, or speech disorder that impedes communication.
• Taking antidepressants, anxiolytics, or neuroleptics that may affect psychological measurement results.

Sponsors & Collaborators

• Universitas Muhammadiyah Surakarta: lead

Study Sites (1)

Indriati Hospital

Sukoharjo, Central Java, 57552, Indonesia

Location

Related Links

• Anxiety reduction in chronic kidney disease (CKD) patients undergoing hemodialysis through acupressure and Quranic recitation interventions
• Penerapan Mindfulness Terhadap Kecemasan Pada Pasien Penyakit Ginjal Kronik (PGK) Yang Menjalankan Hemodialisa Di RSUD Kota Bogor.
• Assessment of prevalence of anxiety in adult population and development of anxiety scale
• Prevalence of poor sleep quality and associated factors among hypertensive patients
• A comparison of ultra-brief cognitive defusion and positive self-affirmation
• Implementasi Hamilton Anxiety Rating Scale. JICON, 10(1), 55-64
• Metode dzikir dalam penurunan tingkat kecemasan pasien gagal ginjal kronik.
• Kualitas tidur dan perubahan tekanan darah pada lansia.
• Prevalence and risk factors for anxiety symptoms in CKD. General Hospital Psychiatry, 69, 27-40
• Autogenic relaxation, movement, and affirmation (RIMA) therapy. Babali Nursing Research, 3(3), 212-220.
• Pengaruh terapi relaksasi otot progresif terhadap kecemasan pasien gagal ginjal kronik
• Insomnia and poor sleep in CKD: A systematic review. Kidney Medicine, 4(5), 100458
• Chronic Kidney Disease
• Pengaruh terapi distraksi MUROTTAL Al-Qur'an terhadap ansietas pasien CKD

MeSH Terms

Conditions

Kidney Failure, Chronic; Anxiety Disorders; Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Renal Insufficiency, Chronic; Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Mental Disorders; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases

Central Study Contacts

Dyan Kurniasari, S.Kep.,Ns

CONTACT

+628122593391; j218240018@student.ums.ac.id

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Graduate Researcher

Model Details: This study uses a parallel assignment quasi-experimental pretest-posttest control group design. Participants are assigned into two groups: an intervention group receiving structured autogenic relaxation combined with Surah Ar-Rahman murottal therapy, and a control group receiving standard hemodialysis care with music listening. Both groups undergo baseline (pretest) and post-intervention (posttest) assessments of anxiety, sleep quality, and hemodynamic parameters. The intervention is administered twice weekly for six weeks.

Study Record Dates

• First Submitted: January 27, 2026
• First Posted: February 17, 2026
• Study Start: March 1, 2026
• Primary Completion: May 31, 2026
• Study Completion: June 30, 2026
• Last Updated: February 17, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

ID (1)